Watchlist Price Alert

NovaBay Pharmaceuticals I... (NBY)

AMEX: NBY · Real-Time Price · USD

0.60

-0.02 (-2.94%)

At close: Jun 18, 2025, 12:02 PM

NovaBay Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-7.1M	-9.64M	-10.61M	-5.82M	-11.04M	-9.66M	-6.54M	-7.4M	-13.15M
Depreciation & Amortization	381K	203K	483K	119K	51K	65K	266K	95K	114K
Stock-Based Compensation	148K	291K	220K	1.15M	701K	621K	594K	2.04M	1.75M
Other Working Capital	n/a	134K	388K	-84K	322K	-41K	-138K	-205K	115K
Other Non-Cash Items	1.98M	4.26M	2.72M	-4.62M	89K	688K	-1.23M	605K	2.31M
Deferred Income Tax	n/a	n/a	n/a	n/a	5.27M	-849K	n/a	n/a	n/a
Change in Working Capital	-595K	750K	533K	-38K	210K	1.2M	1.35M	-1.6M	-3.16M
Operating Cash Flow	-5.18M	-4.13M	-6.65M	-9.19M	-4.72M	-7.93M	-5.57M	-6.27M	-12.13M
Capital Expenditures	-6K	-19K	-112K	-52K	-26K	-19K	-44K	-244K	-160K
Cash Acquisitions	1.07M	n/a	n/a	-11.99M	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	-11.99M	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	1.06M	-19K	-112K	-12.04M	-26K	-19K	-44K	-244K	-160K
Debt Repayment	-1.49M	1.53M	-105K	105K	n/a	2.35M	n/a	n/a	-1.66M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-48K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	132K	384K	1.7M	16.68M	-2.56M	58K	12K	201K	7.43M
Financial Cash Flow	1.5M	1.91M	4.63M	16.79M	9.76M	11.7M	5.6M	201K	19.42M
Net Cash Flow	-2.7M	-2.24M	-2.13M	-4.45M	5.01M	3.75M	-15K	-6.31M	7.13M
Free Cash Flow	-5.19M	-4.15M	-6.77M	-9.24M	-4.75M	-7.95M	-5.61M	-6.51M	-12.29M